Miguel Valderrábano, MD, FACC

Lois and Carl Davis Centennial Chair I, DeBakey Heart & Vascular Center
Professor of Cardiology, Academic Institute
Full Member, Research Institute
Program Director, Clinical Cardiac Electrophysiology Fellowship, Department of Cardiology
Houston Methodist
Weill Cornell Medical College

Research Lab


Dr. Valderrábano came to Houston from Los Angeles where he was director of the Implanted Devices Clinic at the UCLA Cardiac Arrhythmia Center and assistant professor of medicine at UCLA Medical Center.

Dr. Valderrábano received his medical degree from Universidad Autónoma de Madrid (UAM) School of Medicine in Madrid, Spain, and internal medicine training at UCLA. He completed his cardiology and electrophysiology training at Cedars-Sinai Medical Center in Los Angeles, where he was chief cardiology fellow. He then joined the faculty at the David Geffen School of Medicine at UCLA.

Description of Research

Dr. Valderrábano’s research and clinical interests focus on finding new and more effective treatments for atrial fibrillation, including epicardial mapping and ablation. His research has been funded by grants from the American Heart Association and the National Institutes of Health (NIH).

Areas Of Expertise

Atrial fibrillation Epicardial mapping Ablation
Education & Training

Research Fellowship, Cedar-Sinai Medical Center and UCLA SCOR Group
Clinical Fellowship, Cedars-Sinai Medical Center
Internship, UCLA - West Los Angeles VA Medical Center
MD, Universidad Autónoma de Madrid

Chemical Ablation of Ventricular Tachycardia Using Coronary Arterial and Venous Systems
Flautt, T & Valderrábano, M 2022, , Cardiac Electrophysiology Clinics, vol. 14, no. 4, pp. 743-756. https://doi.org/10.1016/j.ccep.2022.08.002

Substrate Ablation by Multivein, Multiballoon Coronary Venous Ethanol for Refractory Ventricular Tachycardia in Structural Heart Disease
Valderrábano, M, Fuentes Rojas, SC, Lador, A, Patel, A, Schurmann, PA, Tapias, C, Rodríguez, D, Carlos Sáenz, L, Malahjfi, M, Shah, DJ, Mathuria, N & Dave, AS 2022, , Circulation, vol. 146, no. 22, pp. 1644-1656. https://doi.org/10.1161/CIRCULATIONAHA.122.060882

Left Atrial Appendage Occlusion Without Fluoroscopy: Optimization by 4D Intracardiac Echocardiography
Flautt, T, Da-Wariboko, A, Lador, A, Patel, A, Guevara, M & Valderrábano, M 2022, , JACC: Cardiovascular Interventions, vol. 15, no. 15, pp. 1592-1594. https://doi.org/10.1016/j.jcin.2022.05.008

Advanced Techniques for Ethanol Ablation of Left Ventricular Summit Region Arrhythmias
Patel, A, Nsahlai, M, Flautt, T, Da-Warikobo, A, Lador, A, Tapias, C, Rodríguez, D, Carlos Sáenz, L, Schurmann, PA, Dave, A & Valderrábano, M 2022, , Circulation: Arrhythmia and Electrophysiology, vol. 15, no. 8, pp. 519-529. https://doi.org/10.1161/CIRCEP.122.011017

Paroxysmal Heart Block After Orthotopic Heart Transplant: Evidence of Intrinsic Cardiac Nerve Activity
Flautt, T, Lador, A & Valderrábano, M 2022, , JACC: Clinical Electrophysiology, vol. 8, no. 6, pp. 802-803. https://doi.org/10.1016/j.jacep.2022.02.006

Non-invasive localization of premature ventricular focus: A prospective multicenter study
Chrispin, J, Mazur, A, Winterfield, J, Nazeri, A, Valderrabano, M & Tandri, H 2022, , Journal of Electrocardiology, vol. 72, pp. 6-12. https://doi.org/10.1016/j.jelectrocard.2022.02.007

Periprocedural Pericardial Effusion Complicating Transcatheter Left Atrial Appendage Occlusion: A Report from the NCDR LAAO Registry
Price, MJ, Valderrabano, M, Zimmerman, S, Friedman, DJ, Kar, S, Curtis, JP, Masoudi, FA & Freeman, JV 2022, , Circulation: Cardiovascular Interventions, vol. 15, no. 5, pp. E011718. https://doi.org/10.1161/CIRCINTERVENTIONS.121.011718

Thermally responsive hydrogel for atrial fibrillation related stroke prevention
Hendrickson, T, Lupo, C, Bauza, G, Tavares, L, Ingram, S, Wang, S, Moreno, M, Tasciotti, E, Valderrabano, M & Taraballi, F 2022, , Materials Today Bio, vol. 14, 100240. https://doi.org/10.1016/j.mtbio.2022.100240

Simultaneous repair of left atrial appendage perforation and appendage closure by transatrial deployment of a septal occluder device: Preclinical and clinical validation
Da-Wariboko, A, Lin, HC & Valderrábano, M 2022, , Heart Rhythm, vol. 19, no. 6, pp. 1022-1030. https://doi.org/10.1016/j.hrthm.2022.01.010

Near-infrared sensitive nanoparticle-mediated photothermal ablation of ventricular myocardium
Mathuria, N, Royal, ALR, Enterría-Rosales, J, Carcamo-Bahena, Y, Terracciano, R, Dave, A, Valderrabano, M & Filgueira, CS 2022, , Heart Rhythm, vol. 19, no. 9, pp. 1550-1556. https://doi.org/10.1016/j.hrthm.2022.05.006

PET-Driven, Voltage-Guided Atrial Endomyocardial Biopsy Clinches the Diagnosis of Cardiac Sarcoidosis
Flautt, T, Lador, A, Da-Wariboko, A, Schwartz, M & Valderrábano, M 2021, , JACC: Case Reports, vol. 3, no. 16, pp. 1764-1768. https://doi.org/10.1016/j.jaccas.2021.08.021

Recent clinical trials in atrial fibrillation
Flautt, T & Valderrábano, M 2021, , Current Opinion in Cardiology, vol. 36, no. 6, pp. 798-802. https://doi.org/10.1097/HCO.0000000000000914

Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion
Simard, T, Jung, RG, Lehenbauer, K, Piayda, K, Pracon, R, Jackson, GG, Flores-Umanzor, E, Faroux, L, Korsholm, K, Chun, JKR, Chen, S, Maarse, M, Montrella, K, Chaker, Z, Spoon, JN, Pastormerlo, LE, Meincke, F, Sawant, AC, Moldovan, CM, Qintar, M, Aktas, MK, Branca, L, Radinovic, A, Ram, P, El-Zein, RS, Flautt, T, Ding, WY, Sayegh, B, Benito-González, T, Lee, OH, Badejoko, SO, Paitazoglou, C, Karim, N, Zaghloul, AM, Agrawal, H, Kaplan, RM, Alli, O, Ahmed, A, Suradi, HS, Knight, BP, Alla, VM, Panaich, SS, Wong, T, Bergmann, MW, Chothia, R, Kim, JS, Pérez de Prado, A, Bazaz, R, Gupta, D, Valderrabano, M, Sanchez, CE, El Chami, MF, Mazzone, P, Adamo, M, Ling, F, Wang, DD, ONeill, W, Wojakowski, W, Pershad, A, Berti, S, Spoon, D, Kawsara, A, Jabbour, G, Boersma, LVA, Schmidt, B, Nielsen-Kudsk, JE, Rodés-Cabau, J, Freixa, X, Ellis, CR, Fauchier, L, Demkow, M, Sievert, H, Main, ML, Hibbert, B, Holmes, DR & Alkhouli, M 2021, , Journal of the American College of Cardiology, vol. 78, no. 4, pp. 297-313. https://doi.org/10.1016/j.jacc.2021.04.098

Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial
Lador, A, Peterson, LE, Swarup, V, Schurmann, PA, Makkar, A, Doshi, RN, DeLurgio, D, Athill, CA, Ellenbogen, KA, Natale, A, Koneru, J, Dave, AS, Giorgberidze, I, Afshar, H, Guthrie, ML, Bunge, R, Morillo, CA, Kleiman, NS & Valderrábano, M 2021, , Heart Rhythm, vol. 18, no. 7, pp. 1045-1054. https://doi.org/10.1016/j.hrthm.2021.01.005

To the Editor—Omissions and misconceptions on vein of Marshall ethanol infusion
Valderrábano, M, Baez-Escudero, JL & Okishige, K 2021, , Heart Rhythm, vol. 18, no. 7, pp. 1251. https://doi.org/10.1016/j.hrthm.2021.03.050

Role of Intracardiac Echography for Transcatheter Occlusion of Left Atrial Appendage
Patel, A & Valderrábano, M 2021, , Cardiac Electrophysiology Clinics, vol. 13, no. 2, pp. 313-323. https://doi.org/10.1016/j.ccep.2021.02.004

Cardioneural ablation in a patient with spinal cord injury and significant sinus bradycardia
Lador, A, Valderrábano, M & Patel, A 2021, , HeartRhythm Case Reports, vol. 7, no. 6, pp. 398-402. https://doi.org/10.1016/j.hrcr.2021.03.016

Alcohol Ablation for Ventricular Tachycardia
Lador, A, Da-Wariboko, A, Tavares, L & Valderrábano, M 2021, , Methodist DeBakey cardiovascular journal, vol. 17, no. 1, pp. 19-23. https://doi.org/10.14797/NECT9586

Sleep Apnea and Atrial Fibrillation: Role of the Cardiac Autonomic Nervous System
Tavares, L, Lador, A & Valderrábano, M 2021, , Methodist DeBakey cardiovascular journal, vol. 17, no. 1, pp. 49-52. https://doi.org/10.14797/ZYUT2951

Exploring New Frontiers in Cardiac Electrophysiology
Valderrábano, M 2021, , Methodist DeBakey cardiovascular journal, vol. 17, no. 1, pp. 6-7. https://doi.org/10.14797/HMRI6337